All Stories

  1. Exploring Machine Learning for Untargeted Metabolomics Using Molecular Fingerprints
  2. CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study
  3. Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody
  4. Old and new strategies in therapy and diagnosis against fungal infections
  5. A synthetic thiol molecule releasing N-acetyl-l-cysteine and cysteamine drives early up-regulation of immunoproteasome subunits in the lymph nodes of mice infected with LP-BM5 leukemia retrovirus
  6. Drug transport by red blood cells
  7. Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis
  8. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
  9. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
  10. Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications
  11. Assessment of a new UV-C light-emitting diode–based technology for air sanitization in indoor sports environments
  12. Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
  13. Sirtuin 6 Regulates the Activation of the ATP/Purinergic Axis in Endothelial Cells
  14. Clonal Spread of Hospital-Acquired NDM-1-Producing Klebsiella pneumoniae and Escherichia coli in an Italian Neonatal Surgery Unit: A Retrospective Study
  15. Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells
  16. Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs
  17. AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability
  18. Targeting SARS‐CoV ‐2 by synthetic dual‐acting thiol compounds that inhibit Spike/ ACE2 interaction and viral protein production
  19. New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
  20. Development and in vitro characterization of a humanized scFv against fungal infections
  21. Functionalized 3D scaffolds for engineering the hematopoietic niche
  22. The host micro-RNA cfa-miR-346 is induced in canine leishmaniasis
  23. Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine
  24. SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy
  25. Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment
  26. CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML
  27. Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
  28. Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in Italy
  29. External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
  30. Airborne Microorganism Inactivation by a UV-C LED and Ionizer-Based Continuous Sanitation Air (CSA) System in Train Environments
  31. Influenza Virus Down-Modulates G6PD Expression and Activity to Induce Oxidative Stress and Promote Its Replication
  32. Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms
  33. SPIO nanoparticles and magnetic erythrocytes as contrast agents for biomedical and diagnostic applications
  34. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS–FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity
  35. Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human Cells
  36. Gastrointestinal Tumors: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer
  37. Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
  38. A new humanized antibody is effective against pathogenic fungi in vitro
  39. Meet the Editorial Board Member
  40. Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
  41. Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency
  42. Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants
  43. In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
  44. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
  45. The nucleoplasmic interactions among Lamin A/C-pRB-LAP2α-E2F1 are modulated by dexamethasone
  46. Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection
  47. Human Red Blood Cells Modulate Cytokine Expression in Monocytes/Macrophages Under Anoxic Conditions
  48. Activation of NRF2 and ATF4 Signaling by the Pro-Glutathione Molecule I-152, a Co-Drug of N-Acetyl-Cysteine and Cysteamine
  49. Carriage of Carbapenem-Resistant Enterobacterales in Adult Patients Admitted to a University Hospital in Italy
  50. Transcriptomic profile of ataxia telangiectasia cells treated for 30 days with a low dose of dexamethasone
  51. Preclinical developments of enzyme-loaded red blood cells
  52. Evaluation of a kDNA-Based qPCR Assay for the Detection and Quantification of Old World Leishmania Species
  53. I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response
  54. Missense mutations in EDA and EDAR genes cause dominant syndromic tooth agenesis
  55. Redox homeostasis as a target for new antimycobacterial agents
  56. Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells
  57. Basic and applied science at the time of COVID‐19
  58. Antiviral Properties of Flavonoids and Delivery Strategies
  59. The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells
  60. Meet Our Editorial Board Member
  61. TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
  62. Redox-Modulating Agents in the Treatment of Viral Infections
  63. Differentiation of Leishmania (L.) infantum, Leishmania (L.) amazonensis and Leishmania (L.) mexicana Using Sequential qPCR Assays and High-Resolution Melt Analysis
  64. Plasmid Replicon Typing of Antibiotic-Resistant Escherichia coli From Clams and Marine Sediments
  65. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication
  66. In Ataxia-Telangiectasia, Oral Betamethasone Administration Ameliorates Lymphocytes Functionality through Modulation of the IL-7/IL-7Rα Axis Paralleling the Neurological Behavior: A Comparative Report of Two Cases
  67. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab
  68. Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes
  69. Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies
  70. Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  71. A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4
  72. Real-time PCR to differentiate among Leishmania (Viannia) subgenus, Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis: Application on Brazilian clinical samples
  73. DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia
  74. A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription
  75. Data on the differentiation among Leishmania (Viannia) spp., Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis in Brazilian clinical samples using real-time PCR
  76. Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study
  77. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
  78. Red Blood Cell Membrane Processing for Biomedical Applications
  79. Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  80. Corrigendum: GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  81. XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT
  82. Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of N-acetyl-cysteine and β-mercaptoethylamine
  83. Secosterol-B affects endoplasmic reticulum structure in endothelial cells
  84. Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38
  85. FKBP5 rs4713916: A Potential Genetic Predictor of Interindividual Different Response to Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease in a Real-Life Setting
  86. Effects in Cancer Cells of the Recombinant l-Methionine Gamma-Lyase from Brevibacterium aurantiacum. Encapsulation in Human Erythrocytes for Sustained l-Methionine Elimination
  87. Identification, Expression and Preliminary Characterization of a Recombinant Bifunctional Enzyme of Photobacterium damselae subsp. piscicida with Glutamate Decarboxylase/Transaminase Activity
  88. Glutathione increase by the n-butanoyl glutathione derivative (GSH-C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus
  89. Magnetic Manipulation of Blood Conductivity with Superparamagnetic Iron Oxide-Loaded Erythrocytes
  90. Biochemical Properties and Oxalate‐Degrading Activity of Oxalate Decarboxylase from Bacillus subtilis at Neutral pH
  91. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
  92. GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  93. The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
  94. Evaluation of PCR-based methods for the identification of enteroaggregative hemorrhagic Escherichia coli in sprouts
  95. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors
  96. Exploiting genetic polymorphisms in metabolic enzymes for rapid screening of Leishmania infantum genotypes
  97. Humanization of Antibodies using a Statistical Inference Approach
  98. Induction of ubiquitin C (UBC ) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress
  99. Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes
  100. Leishmania Infection Induces MicroRNA hsa-miR-346 in Human Cell Line-Derived Macrophages
  101. Real-time PCR applications for diagnosis of leishmaniasis
  102. A new therapy prevents intellectual disability in mouse with phenylketonuria
  103. Comparison of the Diatheva STEC FLUO with BAX System Kits for Detection of O157:H7 and Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) in Ground Beef and Bean Sprout Samples Using Different Enrichment Protocols
  104. Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone
  105. Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice
  106. Ataxia-telangiectasia
  107. Detection of Shiga toxin-producing Escherichia coli (STEC) in ground beef and bean sprouts: Evaluation of culture enrichment conditions
  108. MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
  109. Endothelial cells, endoplasmic reticulum stress and oxysterols
  110. Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells
  111. Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
  112. Engineered red blood cells as therapeutic agents
  113. Endoplasmic reticulum stress and unfolded protein response in infection by intracellular parasites
  114. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia
  115. ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T
  116. Validation and application of a quantitative real-time PCR assay to detect common wheat adulteration of durum wheat for pasta production
  117. The use of kDNA minicircle subclass relative abundance to differentiate between Leishmania (L.) infantum and Leishmania (L.) amazonensis
  118. Comparative analysis of the standard PCR-Based Replicon Typing (PBRT) with the commercial PBRT-KIT
  119. Determination of Interference DuringIn VitroPyrogen Detection: Development and Characterization of a Cell-Based Assay
  120. Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor
  121. Reengineering red blood cells for cellular therapeutics and diagnostics
  122. Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents
  123. Glutathione and its derivatives for the treatment of microbial infections.
  124. Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment
  125. Leishmania infantum Induces Mild Unfolded Protein Response in Infected Macrophages
  126. Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone
  127. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution
  128. Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents
  129. Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response
  130. Enterococcus faeciumST17 from Coastal Marine Sediment Carrying Transferable Multidrug Resistance Plasmids
  131. Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)
  132. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
  133. LP-BM5 infection and glutathione
  134. Erythrocyte-mediated delivery of recombinant enzymes
  135. Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
  136. Validation of a Reversed-Phase High Performance Liquid Chromatography Method for the Simultaneous Analysis of Cysteine and Reduced Glutathione in Mouse Organs
  137. Modulation of Stat-1 in Human Macrophages Infected with Different Species of Intracellular Pathogenic Bacteria
  138. Selection of Vaccine Candidates for Fish Pasteurellosis Using Reverse Vaccinology and an In Vitro Screening Approach
  139. Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma
  140. Retrieving embryo genetic information from spent culture medium
  141. Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants
  142. The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro
  143. Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment
  144. Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions
  145. Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells
  146. Label-free quantification of Tacrolimus in biological samples by atomic force microscopy
  147. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
  148. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
  149. Validation according to ISO/TS 12869:2012 of a molecular method for the isolation and quantification of Legionella spp. in water
  150. Selective protein detection with a dsLNA-functionalized nanopore
  151. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies
  152. Anti influenza therapy
  153. Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources
  154. CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
  155. Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
  156. A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients
  157. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice
  158. Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters
  159. Red Blood Cells as Carriers of Iron Oxide-Based Contrast Agents for Diagnostic Applications
  160. Enhancing neutral lipid content in Skeletonema marinoi through multiple phase growth in a bench photobioreactor
  161. Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: Design and characterization of the enzymatic properties
  162. Promoter-specific relevance of histone modifications induced by dexamethasone during the regulation of pro-inflammatory mediators
  163. Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
  164. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system
  165. Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy
  166. Effect of the N-butanoyl glutathione (GSH) derivative and acyclovir on HSV-1 replication and Th1 cytokine expression in human macrophages
  167. Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy
  168. Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells
  169. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study
  170. An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
  171. Approaches to erythrocyte-mediated drug delivery
  172. Detection and Characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR Green-Based Real-Time PCR and High Resolution Melt Analysis Targeting Kinetoplast Minicircle DNA
  173. Erythrocytes as Carriers for Drugs and Contrast Agents
  174. Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial
  175. Photobacteriosis: Prevention and Diagnosis
  176. Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system
  177. New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI
  178. Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation
  179. Recent advances in synthesis, characterization of hydroxyapatite/polyurethane composites and study of their biocompatible properties
  180. Yin Yang 1 Intronic Binding Sequences and Splicing Elicit Intron-Mediated Enhancement of Ubiquitin C Gene Expression
  181. Genomic DNA in human blastocoele fluid
  182. Neutral Lipid Content and Biomass Production in Skeletonema marinoi (Bacillariophyceae) Culture in Response to Nitrate Limitation
  183. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection
  184. Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis
  185. Magnetic red blood cells as new contrast agents for MRI applications
  186. Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages
  187. Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies
  188. Use of red blood cells as new strategy to avoid the rapid clearance of SPIOs nanoparticles
  189. Isolation of a novel gene from Photobacterium damselae subsp. piscicida and analysis of the recombinant antigen as promising vaccine candidate
  190. Red blood cells as carriers in magnetic particle imaging
  191. Deciphering the single-cell omic: innovative application for translational medicine
  192. CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors
  193. HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
  194. Dexamethasone Partially Rescues Ataxia Telangiectasia-mutated (ATM) Deficiency in Ataxia Telangiectasia by Promoting a Shortened Protein Variant Retaining Kinase Activity
  195. Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines
  196. Palytoxin and an Ostreopsis Toxin Extract Increase the Levels of mRNAs Encoding Inflammation-Related Proteins in Human Macrophages via p38 MAPK and NF-κB
  197. The expression and modulation of CEACAM1 and tumor cell transformation
  198. High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
  199. Microbiological Surveillance of a Bovine Raw Milk Farm Through Multiplex Real-Time PCR
  200. Unique Toxin Profile of a Mediterranean Ostreopsis cf. ovata Strain: HR LC-MSn Characterization of Ovatoxin-f, a New Palytoxin Congener
  201. Development of a multilevel approach for the evaluation of nanomaterials’ toxicity
  202. Erythrocytes as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics
  203. Erythrocytes as carriers for drugs: the transition from the laboratory to the clinic is approaching
  204. Involvement of Stat1 in the Phagocytosis ofM. avium
  205. Red Blood Cells as Magnetic Carriers for MPI Applications
  206. Corrigendum: Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  207. Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
  208. Application of the standard addition method for the absolute quantification of neutral lipids in microalgae using Nile red
  209. Binding force measurement of NF-κB–ODNs interaction: An AFM based decoy and drug testing tool
  210. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules
  211. Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs
  212. Redox Regulation of the Influenza Hemagglutinin Maturation Process: A New Cell-Mediated Strategy for Anti-Influenza Therapy
  213. Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms
  214. Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages
  215. Drug delivery by red blood cells
  216. Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer
  217. A practical and expeditious method for the preparation of the potential anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b′:7,8-b″:10,11-b‴]tetraindole (CTet)
  218. Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational status
  219. Development of an oligonucleotide microarray for the detection and monitoring of marine dinoflagellates
  220. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents
  221. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines
  222. Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients
  223. Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy
  224. The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice
  225. Electrical characterization of DNA-functionalized solid state nanopores for bio-sensing
  226. Human erythrocytes as nanoparticle carriers for magnetic particle imaging
  227. Improved cellular uptake of functionalized single-walled carbon nanotubes
  228. Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy
  229. Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  230. Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking
  231. A multiplex magnetic capture hybridisation and multiplex Real-Time PCR protocol for pathogen detection in seafood
  232. Label-free quantification of activated NF-κB in biological samples by atomic force microscopy
  233. Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24- Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)
  234. Oxidized Ultrashort Nanotubes as Carbon Scaffolds for the Construction of Cell-Penetrating NF-κB Decoy Molecules
  235. Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan
  236. Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
  237. The preventive phase I trial with the HIV-1 Tat-based vaccine
  238. A potent enhancer element in the 5′-UTR intron is crucial for transcriptional regulation of the human ubiquitin C gene
  239. Parallel Conduction of the Phase I Preventive and Therapeutic Trials Based on the Tat Vaccine Candidate
  240. A new platform for Real-Time PCR detection of Salmonella spp., Listeria monocytogenes and Escherichia coli O157 in milk
  241. Expression and characterization of the periplasmic cobalamin-binding protein ofPhotobacterium damselaesubsp.piscicida
  242. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population
  243. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity
  244. Development of a multiplex PCR assay forPhotobacterium damselaesubsp.piscicidaidentification in fish samples
  245. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis
  246. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
  247. PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
  249. Expression, Purification, and Characterization of the Recombinant Putative Periplasmic Hemin-Binding Protein (HutB) ofPhotobacterium damselaesubsp.piscicida
  250. De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-κB/IKK basal activity
  251. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
  252. Erythrocytes as carriers of antisense PNA addressed against HIV-1gag-poltransframe domain
  253. Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria
  254. Analysis of rRNA gene content in the Mediterranean dinoflagellate Alexandrium catenella and Alexandrium taylori: implications for the quantitative real-time PCR-based monitoring methods
  255. HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection
  256. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS)
  257. GSH and analogs in antiviral therapy
  258. High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene
  259. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
  260. High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
  261. Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells
  262. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein
  263. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population
  264. Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study
  265. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
  266. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
  267. Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
  268. Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells
  269. Selective Killing ofMycobacterium avium–Infected Macrophages by Inhibition of Phosphorylated Signal Transducer and Activator of Transcription Type 1
  270. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population
  271. New Biomimetic Constructs for Improved In Vivo Circulation of Superparamagnetic Nanoparticles
  272. Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer
  273. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients
  274. Prolonged Islet Allograft Survival in Diabetic Mice Upon Macrophage Depletion by Clodronate-Loaded Erythrocytes
  275. A three-year longitudinal study on the effects of a diet containing genetically modified Bt176 maize on the health status and performance of sheep
  276. Inhibition of murine AIDS by pro-glutathione (GSH) molecules
  277. Cell-based drug delivery
  278. Detection and quantification of Prymnesium parvum (Haptophyceae) by real-time PCR
  279. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Lamivudine and Tenofovir
  280. Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay
  281. Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge
  282. Detection of Listeria monocytogenes using a commercial PCR kit and different DNA extraction methods
  283. Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment
  284. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
  285. Genotyping OLR1 Gene: A Genomic Biomarker for Cardiovascular Diseases
  286. Immunization with HIV protease peptides linked to syngeneic erythrocytes
  287. Long-term Treatment With Autologous Red Blood Cells Loaded With Dexamethasone 21–Phosphate in Pediatric Patients Affected by Steroid-dependent Crohn Disease
  288. Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy
  289. Current molecular techniques for the detection of microbial pathogens
  290. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir
  291. High throughput HPLC-ESI-MS method for the quantitation of dexamethasone in blood plasma
  292. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer
  293. Candidate HIV-1 Tat vaccine development: from basic science to clinical trials
  294. Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy
  295. Erythrocytes as a controlled drug delivery system: Clinical evidences
  296. Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys
  297. Monitoring of HAB species in the Mediterranean Sea through molecular methods
  298. A combination of diagnostic tools for rapid screening of ovine listeriosis
  299. Monitoring ofAlexandriumspecies in the Mediterranean Sea using a combined filter system–PCR assay detection method
  300. Immune response and protection by DNA vaccines expressing antigen 85B ofMycobacterium tuberculosis
  301. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
  302. The Use of Magnetic Nanoparticles in the Development of New Molecular Detection Systems
  303. Capture probe conjugated to paramagnetic nanoparticles for purification of Alexandrium species (Dinophyceae) DNA from environmental samples
  304. Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules
  305. Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy
  306. In Vitro Inhibition of Promyelocytic Leukemia/Retinoic Acid Receptor-α (PML/RARα) Expression and Leukemogenic Activity by DNA/LNA Chimeric Antisense Oligos
  307. Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease
  308. Development of a magnetic capture hybridization-PCR assay for Listeria monocytogenes direct detection in milk samples
  309. Perturbations of Cell Cycle Control in T Cells Contribute to the Different Outcomes of Simian Immunodeficiency Virus Infection in Rhesus Macaques and Sooty Mangabeys
  310. Development of a qualitative PCR method for the Alexandrium spp. (Dinophyceae) detection in contaminated mussels (Mytilus galloprovincialis)
  311. Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ΔV2 Env
  312. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population
  313. Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients-A Pilot Uncontrolled Study
  314. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
  315. Mechanisms of Action and Antiproliferative Properties of Brassica oleracea Juice in Human Breast Cancer Cell Lines
  316. Prognostic Role of Thymidylate Synthase Polymorphisms in Gastric Cancer Patients Treated with Surgery and Adjuvant Chemotherapy
  317. Development of new procedures for the isolation of phytoplankton DNA from fixed samples
  318. Prognostic Role of Interleukin-1β Gene and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients With Advanced Gastric Cancer
  319. Erythrocyte-based drug delivery
  320. Loss of CD127 Expression Defines an Expansion of Effector CD8+T Cells in HIV-Infected Individuals
  321. Macrophage depletion induced by clodronate-loaded erythrocytes
  322. Targeting Nucleotide Dimers Containing Antiviral Nucleosides
  323. Bovine hexokinase type I: Full-length cDNA sequence and characterisation of the recombinant enzyme
  324. Editorial
  325. Locked Nucleic Acids (LNA): Versatile Tools for Designing Oligonucleotide Decoys with High Stability and Affinity
  326. Direct detection of Listeria monocytogenes from milk by magnetic based DNA isolation and PCR
  327. Development of a Real-Time PCR Assay Using SYBR Green I for Provirus Load Quantification in a Murine Model of AIDS
  328. Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application
  329. Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients
  330. Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer
  331. Purification and characterization of a recombinant listeriolysin O expressed in Escherichia coli and possible diagnostic applications
  332. Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity
  333. Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages
  334. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs
  335. Development of a Real-Time PCR Assay for Rapid Detection and Quantification of Alexandrium minutum (a Dinoflagellate)
  336. Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid
  337. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients
  338. Predictive and Prognostic Role of E-Cadherin Protein Expression in Patients with Advanced Gastric Carcinomas Treated with Palliative Chemotherapy
  339. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility
  340. Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency
  341. Drug Delivery through Phagocytosis of Red Blood Cells
  342. Specific Changes in the Posttranslational Regulation of Nucleolin in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  343. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression
  344. Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections
  345. A new one-step RT-PCR method for virus quantitation in murine AIDS
  346. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge
  347. Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy
  348. High-level expression of the Listeria monocytogenes listeriolysin O in Escherichia coli and preliminary characterization of the purified protein
  349. Marine diatom growth on different forms of particulate silica: evidence of cell/particle interaction
  350. The G/A Nucleotide Change at cDNA Position 2494 in the E-Cadherin Gene (CDH1): Analysis in Italian Patients
  351. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model
  352. Seasonal Blooms of the HAB Dinoflagellate Alexandrium taylori Balech in a New Mediterranean Area (Vulcano, Aeolian Islands)
  353. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer
  354. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine
  355. Repeated Cycles of Alternate Administration of Fludarabine and Zidovudine Plus Didanosine Inhibits Murine AIDS and Reduces Proviral DNA Content in Lymph Nodes to Undetectable Levels
  356. HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials
  357. Inhibition of Macrophage iNOS by Selective Targeting of Antisense PNA†
  358. Design and characterization of decoy oligonucleotides containing locked nucleic acids
  359. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
  360. Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals
  361. Modulation of ICAM-1 Expression in ECV304 Cells by Macrophage-Released Cytokines
  362. The potency of acyclovir can be markedly different in different cell types
  363. Inhibition of Proteasome Activity Strongly Affects Kiwifruit Pollen Germination. Involvement of the Ubiquitin/Proteasome Pathway as a Major Regulator
  364. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus
  365. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and 9-(R)-2-(Phosphono Methoxypropyl)adenine
  366. Identification of Blood Erythroid Markers Useful in Revealing Erythropoietin Abuse in Athletes
  367. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis
  368. Antioxidant capacity of extra-virgin olive oils
  369. New drug combinations for the treatment of murine AIDS and macrophage protection
  370. Identification of the main ubiquitination site in human erythroid α-spectrin
  371. The Ubiquitin-Dependent Proteolytic System and other Potential Targets for the Modulation of Nuclear Factor-kB (NF-kB)
  372. A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus
  373. Structure of the 5′ region of the human hexokinase type I (HKI) gene and identification of an additional testis-specific HKI mRNA
  374. Ubiquitin/proteasome system
  375. Selective Inhibition of NF-kB Activation and TNF-α Production in Macrophages by Red Blood Cell-Mediated Delivery of Dexamethasone
  376. Identification of ubiquitinated repeats in human erythroid α-spectrin
  377. Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate
  378. New Treatment Protocol Including Lympholytic and Antiretroviral Drugs to Inhibit Murine AIDS
  379. Metabolism, mitochondrial uptake and toxicity of 2′,3′-dideoxycytidine
  380. Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme–membrane association control
  381. Influence of nutrient ratios on the in vitro extracellular polysaccharide production by marine diatoms from the Adriatic Sea
  382. Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients
  384. Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover
  386. Alteration of α-spectrin ubiquitination due to age-dependent changes in the erythrocyte membrane
  387. Protein Degradation and Apoptotic Death in Lymphocytes during Fiv Infection: Activation of the Ubiquitin–Proteasome Proteolytic System
  388. Liposomes as carriers of the antiretroviral agent dideoxycytidine-5′-triphosphate
  389. Synthesis and Biological Application of a New Heterodinucleotide with Both Anti-HSV and Anti-HIV Activity
  390. cDNA Sequence of the Human Erythroid -Spectrin: Identification of a Base Deletion in the Sequence Database
  391. Efficient inhibition of macrophage TNF-α production upon targeted delivery of K48R ubiquitin
  392. Heterodimer-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiviral Drug Azidothymidine and the Antimycobacterial Drug Ethambutol
  393. Expression, Purification, and Characterization of a Recombinant Erythroid-Specific Hexokinase Isozyme
  394. Competitive PCR for Quantification of BM5d Proviral DNA in Mice with AIDS
  395. Drug delivery and targeting system
  396. Structure of the human hexokinase type I gene and nucleotide sequence of the 5′ flanking region
  397. Macrophage Protection Against Human Immunodeficiency Virus or Herpes Simplex Virus by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and Acyclovir
  398. AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Homologous Erythrocytes as a Delivery System for Preferential Immunization with Putative Protective Antigens
  399. Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide
  400. Structure and expression of the human ubiquitin fusion–degradation gene (UFD1L)
  401. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  402. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  403. Expression of hexokinase mRNA in human hippocampus
  404. Use of Nonvolatile Buffers in Liquid Chromatography/Mass Spectrometry:  Advantages of Capillary-Scale Particle Beam Interfacing
  405. Antiretroviral Effect of Combined Zidovudine and Reduced Glutathione Therapy in Murine AIDS
  406. Oxidative Protein Damage and Degradation in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  407. Ubiquitin conjugation to endogenous proteins in the dormant tuber of Helianthus tuberosus and during the first cell cycle
  408. 2′,3′-Dideoxycytidine cytotoxicity in human macrophages
  409. Targeting antiviral nucleotide analogues to macrophages
  410. Up-Regulation of the Ubiquitin-Conjugating and Proteolytic Systems in Murine Acquired Immunodeficiency Syndrome
  411. Molecular bases of hexokinase deficiency
  412. The Inhibitory Effect of ddC on Human Immunodeficiency Virus Replication Diminishes in Cells that are Chronically Exposed to the Drug
  413. Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice
  414. Structural determinants that make hexokinase susceptible to ubiquitin-and ATP- dependent proteolysis
  415. Structure of the human hexokinase type I gene
  416. Identification of α-Spectrin Domains Susceptible to Ubiquitination
  417. Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidine
  418. Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes
  419. Inhibition of Murine AIDS by Reduced Glutathione
  420. Inhibition of Murine AIDS by Combination of AZT and Dideoxycytidine 5'-Triphosphate
  422. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
  423. Azidothymidine Homodinucleotide-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiretroviral Drug Azidothymidine
  424. High-Level Expression and Purification of a Human “Mini”-hexokinase
  425. Assignment of the hexokinase type 3 gene (HK3) to human chromosome band 5q35.3 by somatic cell hybrids and in situ hybridization
  426. Three new mutations (P183T, V150L, 528insG) and eleven sequence polymorphisms in Italian patients with galactose-1-phosphate uridyltransferase (GALT) deficiency
  427. Lactate catabolism by enzyme‐loaded red blood cells
  428. 2′,3′-Dideoxycytidine metabolism in a new drug-resistant cell line
  429. Inhibition of HIV-1 and LP-BM5 Replication in Macrophages by Dideoxycytidine and Dideoxycytidine 5′-Triphosphate
  430. Effect of Antiviral Treatments on the Bone Marrow in Murine AIDS
  431. 2′,3′-Dideoxycytidine induced drug resistance in human cells
  432. Efficacy and Toxicity of Long-Term Administration of 2′,3′-dideoxycytidine in the LP-BM5 Murine-Induced Immunodeficiency Model
  434. FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5′-triphosphate
  435. Ubiquitin Is Conjugated to the Cytoskeletal Protein α-Spectrin in Mature Erythrocytes
  436. Hexokinase Mutations that Produce Nonspherocytic Hemolytic Anemia
  437. Effect of heat stress on polyamine content and protein pattern in Skeletonema costatum
  438. Modulated red blood cell survival by membrane protein clustering
  439. Red blood cells as a delivery system for AZT
  440. Targeting dexamethasone to macrophages
  441. Preparation and characterization of biotinylated red blood cells
  442. Feline Immunodeficiency Virus Infection of Macrophages:In Vitroandin VivoInhibition by Dideoxycytidine-5′-triphosphate-Loaded Erythrocytes
  443. Red blood cell phagocytosis following hexokinase inactivation
  444. Localization and age-dependent expression of hexokinase mRNA in the rat brain
  445. The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system
  446. HPLC Analysis of Taurine in Human Plasma Sample Using the Dabs-Ci Reagent with Sensitivity at Picomole Level
  447. The female longevity phenomenon. Hypotheses on some molecular and cell biology aspects
  448. Methanol detoxification by enzyme‐loaded erythrocytes
  449. Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara district
  450. Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro
  451. Red Blood Cell Aging. Proceedings of a Symposium Held in Urbino, Italy, 24-26 September 1990.Mauro Magnani , Antonio De Flora
  452. The bone marrow in murine AIDS
  453. Direct observation of hexokinase translocation in stimulated macrophages
  454. Red blood cell age dependent modifications of inositol 1,4,5-trisphosphate
  455. Glucose-6-Phosphate Dehydrogenase Nucleotide 1311 Polymorphism in Central Italy (Marche Region)
  456. Intracellular distribution of hexokinase in rabbit brain
  457. In vitro and in vivo toxicity of 2′,3′-dideoxycytidine in mice
  458. Intracellular Distribution of Protein as a Determinant for Ubiquitination and Proteolytic Degradation
  459. Red blood cells as an antigen‐delivery system
  460. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.
  461. A recombinant human ‘mini’-hexokinase is catalytically active and regulated by hexose 6-phosphates
  462. In vitro targeting of erythrocytes to cytotoxic T‐cells by coupling of Thy‐1.2 monoclonal antibody
  463. Increased glucose metabolism by enzyme‐loaded erythrocytes in vitro and in vivo normalization of hyperglycemia in diabetic mice
  464. Acetaldehyde Oxidation by Aldehyde Dehydrogenase Loaded Erythrocytes
  465. Analysis of amino acids as DABS-derivatives with a sensitivity to the femtomole level using RP-HPLC narrow-bore columns
  466. Comparison of Uricase-Bound and Uricase-Loaded Erythrocytes as Bioreactors for Uric Acid Degradation
  467. Normalization of Hyperglycemia in Diabetic Mice by Enzyme-Loaded Erythrocytes
  468. Red Blood Cells as Advanced Drug Delivery Systems for Antiviral Nucleoside Analogues
  469. Xenobiotic Detoxification by GSH-Loaded Erythrocytes
  470. The Use of Resealed Erythrocytes as Carriers and Bioreactors
  471. Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli
  472. Human red blood cells as bioreactors for the inactivation of harmful xenobiotics
  473. Cell age dependent decay of human erythrocytes glutathione S-transferase
  474. Red Blood Cell Aging
  475. Free Radicals Promote “In Vitro” a Different Intracellular Decay of Rabbit Reticulocyte and Erythrocyte Glycolytic Enzymes
  476. Glucose-6-Phosphate Dehydrogenase Lodi^844C: A Study on Its Expression in Blood Cells and Muscle
  477. In vitro toxicity and metabolism of 2′,3′-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity
  478. Role and Mechanism of Hexokinase Decay During Reticulocyte Maturation and Cell Aging
  479. Immunological quantification of human hexokinase type I
  480. A nonlinear three-compartiment model for the administration of 2′,3′-dideoxycytidine by using red blood cells as bioreactors
  481. Preparation and characterization of monoclonal antibodies to human hexokinase type I
  482. Hexokinase: one gene or two [letter; comment]
  483. ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts
  484. Similarities and differences between human and rat hexokinases type I
  486. Acetaldehyde Dehydrogenase-Loaded Erythrocytes as Bioreactors for the Removal of Blood Acetaldehyde
  487. Cell age dependent decay of human erythrocytes glucose-6-phosphate isomerase
  488. Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity
  489. Improved stability of 2,3‐bisphosphoglycerate during storage of hexokinase‐overloaded erythrocytes
  490. Reversed-phase high-performance liquid chromatography separation of dimethylaminoazobenzene sulfonyl- and dimethylaminoazobenzene thiohydantoin-amino acid derivatives for amino acid analysis and microsequencing studies at the picomole level
  491. Effects of Ca2+ and lipoxygenase inhibitors on hexokinase degradation in rabbit reticulocytes
  492. Human Red Blood Cell Loading with Hexokinase-Inactivating Antibodies
  493. Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samples
  494. Improved metabolic properties of hexokinase-overloaded human erythrocytes
  495. Hexokinase type I multiplicity in human erythrocytes
  496. Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress
  497. Effect of phenylhydrazine on red blood cell metabolism
  498. Simultaneous Preparation from Human Placenta of Several Enzymes of Glucose Metabolism
  499. Superoxide anions are required for the inactivation ofEscherichia coli induced by high concentrations of hydrogen peroxide
  500. Hexokinase microheterogeneity in rabbit red blood cells and its behaviour during reticulocytes maturation
  501. Effect of age on some properties of mice erythrocytes
  502. Membrane-Bound Immunoglobulins Increase during Red Blood Cell Aging
  503. Purification, properties, and evidence for two subtypes of human placenta hexokinase type I
  504. The interaction of phosphorylated sugars with human hexokinase I
  505. Adenine and pyridine nucleotides during rabbit reticulocyte maturation and cell aging
  506. Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine
  507. Relationships between the age-dependent decay of glucose-1,6-bisphosphate synthesis, phosphoribomutase and phosphoglucomutase in human red cells
  508. Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency
  509. First trimester monitoring of a pregnancy at risk for glucose phosphate isomerase deficiency
  510. Human erythrocyte hexokinases are immunologically related
  511. Rat red blood cell hexokinase purification, properties and age-dependence
  512. Increased Erythrocyte Adenosine Deaminase Activity without Haemolytic Anaemia
  513. Redox and Energetic State of Red Blood Cells in G6PD Deficiency, Heterozygous β-Thalassemia and the Combination of Both
  514. Complete high-performance liquid chromatographic separation of 4-N,N-dimethylaminoazobenzene-4′-thiohydantoin and 4-dimethylaminoazobenzene-4′-sulphonyl chloride amino acids utilizing the same reversed-phase column at room temperature
  515. Hereditary nonspherocytic hemolytic anemia due to a new hexokinase variant with reduced stability
  516. Human erythrocyte hexokinase deficiency: a new variant with abnormal kinetic properties
  517. Hexokinase in human chorionic villi
  518. Regulatory properties of human erythrocyte hexokinase during cell ageing
  519. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells
  520. Red blood cell adenine nucleotides abnormalities in down syndrome
  521. Hexokinase in developing rabbit erythroid cells
  522. A new direct radioassay for the determination of true erythrocyte hexokinase activity
  523. Relationship between the rate of erythrocyte hexose monophosphate pathway and the glucose 6-phosphate concentration
  524. Rabbit red blood cell hexokinase:intracellular distribution during reticulocytes maturation
  525. Regulatory properties of rabbit red blood cell hexokinase at conditions close to physiological
  526. Increased Activity of Glutathione S-Transferase and Fast Decay of Reduced Glutathione in Fanconi’s Anemia Erythrocytes
  527. Rabbit red blood cell hexokinase
  528. Red Blood Cell Hexokinase in Fanconi’s Anemia
  529. Regional Mapping of Hexokinase-1 within the Short Arm of Chromosome 10
  530. Pig red blood cell hexokinase: Evidence for the presence of hexokinase types II and III, and their purification and characterization
  531. Pig red blood cell hexokinase: Regulatory characteristics and possible physiological role
  532. Prenatal prediction of duplication 10q24→qter by gene dosage of GOT1 on uncultured amniotic cells
  533. The age-dependent metabolic decline of the red blood cell
  534. Red Blood Cell Hexokinase in Tumor Bearing Mice
  535. Red blood cell glucose metabolism in trisomy 10p: possible role of hexokinase in the erythrocyte
  536. Relationship between Erythrocyte Hexokinase in Cancer Patients and Red Cell Age
  537. Red Blood Cell Galactokinase Activity and Presenile Cataracts
  538. Regional mapping of the locus for hexokinase-1 (HK1)
  539. Molecular forms of red blood cell hexokinase
  540. Solubilization, purification, and properties of rabbit brain hexokinase
  541. Adult and fetal galactokinases in human red blood cells
  542. Chromatographic fractionation of multiple forms of red blood cell hexokinase
  543. Cell survival and glutathione reductase
  544. A New Variant of Galactokinase
  545. [1] Hexokinase from rabbit red blood cells
  546. Human Erythrocyte Galactokinase: A Population Survey
  547. Expression of GALT in two unrelated 9p- patients. Evidence for assignment of the GALT locus to the 9p21 band
  548. The possibility of prenatal diagnosis by gene dosage: Confirmation of duplication 10q24→qter from Got-l activity in fetal erythrocytes
  549. Hexokinase isozymic pattern during red cell aging
  550. Action of oxidized and reduced glutathione on rabbit red blood cell hexokinase
  551. Galactokinase activity and red blood cell age
  552. Studies on the use of Sepharose-N-Aminohexanoyl-Glucosamine for purification of rabbit red blood cell hexokinase
  553. Spectrophotometric analysis of interferences due to polyols in the assay of protein by Lowry's method
  554. Comparative studies of glucose metabolism on mammals' red blood cells
  555. Decay pattern of rabbit erythrocyte hexokinase in cell aging
  556. Comparative studies of galactokinase activity on mammal's red blood cells
  557. Confirmation of regional assignment of nucleoside phosphorylase to band 14q13 by gene-dosage studies
  558. Comparative studies on red blood cell glucose phosphorylating activities of mammals
  559. Glucokinase and Hexokinase in Pig Erythrocytes
  560. Relationship between glucose phosphorylating activities and erythrocyte age
  561. Immobilization of Enzymes and Proteins on Red Blood Cells
  562. An Ex Vivo Erythrocyte Model for Investigating Oxidative Metabolism